T2 Biosystems jumps 49% after saying its diagnostic test can detect COVID-19 variants (TTOO)Business Insider • 01/12/21
T2 Biosystems T2SARS-CoV-2™ Panel Proves Effective Amid Global Rise in Variants of the SARS-CoV-2 VirusGlobeNewsWire • 01/11/21
T2 Biosystems to Participate in the Canaccord Genuity Virtual MedTech & Diagnostics ForumGlobeNewsWire • 11/12/20
T2 Biosystems, Inc. (TTOO) CEO John Sperzel on Q3 2020 Results - Earnings Call TranscriptSeeking Alpha • 11/05/20
T2 Biosystems to Report Third Quarter 2020 Financial Results on November 4, 2020GlobeNewsWire • 10/14/20
Is T2 Biosystems (TTOO) Outperforming Other Medical Stocks This Year?Zacks Investment Research • 10/08/20
T2 Biosystems Announces BARDA Exercise of Contract Option 1 Valued at $10.5 MillionGlobeNewsWire • 09/30/20
Is T2 Biosystems (TTOO) Stock Outpacing Its Medical Peers This Year?Zacks Investment Research • 09/22/20
T2 Biosystems Announces CMS Approval of a New Technology Add-On Payment for the T2Bacteria® Panel for a Second YearGlobeNewsWire • 09/04/20
T2 Biosystems Receives FDA Emergency Use Authorization for COVID-19 Molecular Diagnostic TestGlobeNewsWire • 08/31/20
Do Options Traders Know Something About T2 Biosystems (TTOO) Stock We Don't?Zacks Investment Research • 08/18/20
T2 Biosystems, Inc. (TTOO) CEO John Sperzel on Q2 2020 Results - Earnings Call TranscriptSeeking Alpha • 08/12/20